In this CE Concepts Grand Rounds series, expert faculty will explore the latest clinical trial data on novel treatment options for patients with resistant/recurrent (R/R) CLL/SLL, utilization of an evidence-based approach for personalizing treatment for patients with R/R MCL, and prioritization of patient adherence and active engagement through development of multidisciplinary frameworks to oversee and address adverse events. The faculty will also provide insight through case-based discussions.
Associate Professor of Clinical Medicine
Weill Cornell Medicine
Division of Hematology & Medical Oncology
New York, NY
In this CE Concepts livestream symposium, faculty will apply NF1 diagnostic and oncologic monitoring guidelines to support early recognition of NF1-PNs in pediatric patients. Learners will be shown how to incorporate MEK inhibitors in the management of NF1-PNs in pediatric patients within care pathways that extend into adult-focused settings through evidence-based monitoring and safety support. Faculty will model the application of interprofessional care coordination and continuity planning strategies in clinical practice to support consistent management of patients with NF1 across pediatric and adult care settings.
In this CE Concepts live symposium, faculty will apply NF1 diagnostic and oncologic monitoring guidelines to support early recognition of NF1-PNs in pediatric patients. Learners will be shown how to incorporate MEK inhibitors in the management of NF1-PNs in pediatric patients within care pathways that extend into adult-focused settings through evidence-based monitoring and safety support. Faculty will model the application of interprofessional care coordination and continuity planning strategies in clinical practice to support consistent management of patients with NF1 across pediatric and adult care settings.
In this CE Concepts live symposium, expert faculty will review the latest clinical evidence for integrating FRα testing into treatment decision-making as well as practical strategies for selecting and sequencing FRα-targeted ADCs, including anticipating and managing toxicities, to deliver personalized, multidisciplinary care with greater confidence in the rapidly evolving PROC treatment landscape.
In this CE Concepts livestream symposium, expert faculty will incorporate patient-reported pain and quality-of-life data into treatment decision-making for patients with NF1-associated plexiform neurofibromas. Learners will be shown how to assess evidence‑based strategies for integrating MEK inhibitor therapy with surgery in the multidisciplinary management of patients with NF1‑PNs. Faculty will discuss structured, evidence-based strategies to anticipate, monitor, and manage MEK inhibitor-related toxicities in patients with NF1-PNs while maintaining dose intensity and minimizing treatment discontinuation across pediatric and adult care settings.
In this CE Concepts live symposium, expert faculty will incorporate patient-reported pain and quality-of-life data into treatment decision-making for patients with NF1-associated plexiform neurofibromas. Learners will be shown how to assess evidence‑based strategies for integrating MEK inhibitor therapy with surgery in the multidisciplinary management of patients with NF1‑PNs. Faculty will discuss structured, evidence-based strategies to anticipate, monitor, and manage MEK inhibitor-related toxicities in patients with NF1-PNs while maintaining dose intensity and minimizing treatment discontinuation across pediatric and adult care settings.